Zhejiang HuaIoMT Biotechnology Co., Ltd. was established in 2020. The company leverages domestic technical expertise to specialize in veterinary diagnostics and related fields, establishing a fully integrated industrial chain encompassing production, research and development (R&D), and sales. Comprehensive original technological capabilities have been developed across reagent R&D, disk-shaped chip design, and the development of instruments and application testing systems. Building upon core technologies including microfluidics, precision electronics, and lyophilized microsphere technology, the company has established a complete system solution portfolio, with point-of-care testing (POCT) instant diagnostic reagents as its flagship products. The company's product offerings primarily encompass veterinary fluorescent immunoassay analyzers and veterinary microfluidic biochemical analyzers.Commercialized core technology products include microfluidic lyophilized microsphere biochemical test chips and corresponding biochemical analyzers, as well as consumables for companion animal disease diagnostics. The company is currently advancing the market launch of microfluidic lyophilized microsphere immunoassay products. These technologies find wide application across diverse sectors including veterinary clinics, pet hospital chains, third-party laboratories, and leading Chinese universities.